Abstract
This presentation focuses on an aspect of adrenal insufficiency, namely congenital adrenal hyperplasia (CAH). It focuses on routine management with hydrocortisone, but also explores new treatment regimes and also novel monitoring methods.
| Original language | English |
|---|---|
| Publication status | Published - 1 Jan 2024 |
| Event | Canadian Pediatric Endocrine Group - Duration: 1 Jan 2024 → … |
Conference
| Conference | Canadian Pediatric Endocrine Group |
|---|---|
| Period | 1/01/24 → … |
Keywords
- CAH, steroid, hydrocortisone